Spectral Medical Inc. (TSE:EDT – Get Free Report)’s share price shot up 2% on Monday. The stock traded as high as C$1.07 and last traded at C$1.02. 64,450 shares traded hands during trading, an increase of 22% from the average session volume of 52,794 shares. The stock had previously closed at C$1.00.
Spectral Medical Trading Down 2.8%
The company has a market cap of C$305.30 million, a price-to-earnings ratio of -34.67 and a beta of 0.86. The company’s fifty day moving average price is C$1.10 and its two-hundred day moving average price is C$1.30. The company has a quick ratio of 0.45, a current ratio of 0.61 and a debt-to-equity ratio of 26.03.
Spectral Medical (TSE:EDT – Get Free Report) last posted its earnings results on Friday, November 6th. The company reported C($0.01) earnings per share (EPS) for the quarter. The firm had revenue of C$0.28 million for the quarter. Research analysts expect that Spectral Medical Inc. will post -0.05 earnings per share for the current year.
About Spectral Medical
Spectral is a Phase 3 company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin¿ (‘PMX’). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s FDA cleared Endotoxin Activity Assay (EAA¿), the clinically available test for endotoxin in blood. PMX is approved for therapeutic use in Japan and Europe, licensed by Health Canada, and has been used safely and effectively with over 360,000 units sold worldwide to date.
See Also
- Five stocks we like better than Spectral Medical
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
